BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Mallinckrodt Launches Magnacet(TM) Tablets


6/7/2007 11:32:45 AM

ST. LOUIS, June 7 /PRNewswire/ -- Mallinckrodt Brand Pharmaceuticals today announced that it is providing a new pain management drug, called Magnacet(TM) (oxycodone HCl /acetaminophen tablets CII). Magnacet is the only available Oxycodone product coupled with 400mg of acetaminophen, a unique dosage that gives physicians flexibility in treating patients with moderate to moderately severe pain.

Magnacet is indicated for the relief of moderate to moderately severe pain. The most frequently observed adverse reactions include lightheadedness, dizziness, sedation, nausea and vomiting. Oxycodone can produce drug dependence of the morphine-type and, therefore, has the potential for being abused.

"Mallinckrodt Brands is committed to offering additional treatment options that help healthcare providers improve patient care," says Marco Polizzi, executive business director for Mallinckrodt Brand Pharmaceuticals, a unit of Tyco Healthcare/Mallinckrodt. "Magnacet is an example of our efforts to provide proven molecules in unique combinations and strengths in an area such as pain, where it is important that medical professionals are able to tailor treatments for specific needs of patients."

According to Wolters Kluwer Health data, more than 200 million prescriptions were written in the pain market in 2006, representing a 9 percent increase from the previous year. The U.S. Food and Drug Administration (FDA) approved Magnacet in May 2006. The 400mg dose of acetaminophen provides another option for physicians seeking additional dosing flexibility in treating patients with moderate to moderately severe pain.

Magnacet is available in 2.5/400, 5/400, 7.5/400, and 10/400mg tablets through wholesalers and pharmacies in the United States. For more information, including the full prescribing information, please call Mallinckrodt at 1-888-744-1414.

About Mallinckrodt Pharmaceuticals Brands

Mallinckrodt Pharmaceuticals Brands division is dedicated to providing quality pharmaceutical products to help healthcare professionals enhance patient care. The organization consists of over 120 sales and marketing personnel in the continental United States and is engaged in the promotion of a broad range of medications focused on sleep, depression, palliative care, pain management and other areas of the Central Nervous System. For more information, visit http://www.pharmaceuticals.mallinckrodt.com/brand or http://www.tycohealthcare.com.

About Tyco Healthcare/Mallinckrodt

Tyco Healthcare's Mallinckrodt division offers a diverse line of imaging and pharmaceutical products that diagnose disease and relieve pain. As a major business segment of Tyco International Ltd., Tyco Healthcare manufactures, distributes and services an extensive product line including disposable medical supplies, monitoring equipment, innovative wound closure products, advanced surgical devices, medical instruments and bulk analgesic pharmaceuticals. With industry-leading brand names such as Autosuture, Kendall, Mallinckrodt, Nellcor, Puritan Bennett, Syneture and Valleylab, Tyco Healthcare products are found in virtually every healthcare setting.

Trademarks are owned by Mallinckrodt Inc.

Mallinckrodt Inc.

CONTACT: JoAnna Schooler, Media Relations, Tyco Healthcare Mallinckrodt,+1-314-654-3543, joanna.schooler@tycohealthcare.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES